🇺🇸 FDA
Patent

US 9062288

Therapeutic methods using adipose tissue-derived cell suspensions comprising adipocytes

granted A61KA61K35/12A61K35/35

Quick answer

US patent 9062288 (Therapeutic methods using adipose tissue-derived cell suspensions comprising adipocytes) held by Regeneus LTD expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regeneus LTD
Grant date
Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K35/12, A61K35/35